clarithromycin has been researched along with Nasal Catarrh in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 6 (20.00) | 29.6817 |
| 2010's | 19 (63.33) | 24.3611 |
| 2020's | 4 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Askari, M; Khezri, M; Zoghi, G | 1 |
| Han, M; Hu, X; Li, H; Shu, H; Wang, Y; Wen, W; Xu, H; Yu, Z; Zhang, J | 1 |
| Debie, G; Horoi, M; Kampouridis, S; Lechien, JR; Mahillon, V; Muls, V; Rodriguez, A; Saussez, S; Thill, MP | 1 |
| Ho, NH; Hsu, AT; Lin, CF; Merton, AT; Wang, MC; Wang, YP; Wu, PS | 1 |
| Chen, F; Deng, J; Fu, Q; Lai, Y; Luo, Q; Ou, C; Shi, J; Xu, R | 1 |
| Cao, PP; Liao, B; Liu, JX; Liu, Z; Long, XB; Ma, J; Ning, Q; Wang, H; Zeng, M | 1 |
| Huang, Z; Zhou, B | 1 |
| Beard, D; Blackshaw, H; Boardman, J; Carpenter, J; Clarke, CS; Cook, J; Denaxas, S; Durham, S; Hopkins, C; le Conte, S; Little, P; Lund, V; Morris, S; Philpott, C; Schilder, A; Sones, W; Thomas, M; Vennik, J | 1 |
| Bhargava, SK; Peethambaran, K | 1 |
| Ding, M; Fan, Y; Hong, H; Li, H; Luo, Q; Lv, M; Shi, J; Xia, W; Xu, R | 1 |
| Lopatin, A; Varvyanskaya, A | 1 |
| Chen, C; Cui, Y; Hu, S; Liu, Z; You, X | 1 |
| Cao, PP; Cui, YH; Li, ZY; Liu, Z; Ma, J; Wang, H; Zeng, M | 1 |
| Shimizu, T; Suzaki, H | 1 |
| Ahmed, S; Bewick, J; Carrie, S; Erskine, S; Hopkins, C; Morris, S; Philpott, CM; Sama, A; Sunkaraneni, V; Woods, J | 1 |
| Cervin, A; Coman, WB; Greiff, L; Mackay-Sim, A; Wallwork, B | 1 |
| Harada, T; Haruna, S; Hirakawa, K; Ichimura, K; Kase, Y; Kawauchi, H; Kurono, Y; Majima, Y; Moriyama, H; Naito, K; Suzaki, H; Takeuchi, K | 1 |
| Chen, F; Chen, R; Fan, Y; Fu, Q; Li, H; Li, Z; Liu, W; Liu, Z; Luo, Q; Shi, J; Xu, G; Xu, R; Xu, Y; Zuo, K | 1 |
| Feng, Z; Hong, Y; Li, Q; Li, X; Liu, J; Liu, L; Lu, X; Wan, Y; Zhong, G | 1 |
| Kuian, IuS; Mokronosova, MA | 1 |
| Celik, HH; Korkmaz, H; Ocal, B; Ozdek, A; Saylam, G; Tatar, EÇ; Tatar, I | 1 |
| Bobacheva, TIu; Piskunov, GZ | 1 |
| Bobacheva, TIu | 1 |
| Hamajima, Y; Hashiba, M; Murakami, S; Nakamura, Y; Nakayama, M; Ohno, N; Ozaki, S; Suzuki, M; Yokota, M | 1 |
| Cervin, A; Coman, W; Feron, F; Mackay-Sim, A; Wallwork, B | 1 |
| Baczek, M; Hassmann-Poznańska, E; Skotnicka, B | 1 |
| Ferguson, BJ | 1 |
| Balatsouras, DG; Homsioglou, E; Kouskoukis, C; Rallis, E; Verros, C | 1 |
| Cervin, A; Wallwork, B | 1 |
| Druce, H; Palmer, R; Ramirez, OE; Rubin, BK | 1 |
3 review(s) available for clarithromycin and Nasal Catarrh
| Article | Year |
|---|---|
Clarithromycin for the treatment of adult chronic rhinosinusitis: a systematic review and meta-analysis.
Topics: Administration, Intranasal; Administration, Oral; Adult; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Glucocorticoids; Humans; Nasal Lavage; Nasal Sprays; Randomized Controlled Trials as Topic; Rhinitis; Sinusitis; Sodium Chloride | 2019 |
Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chronic Disease; Clarithromycin; Erythromycin; Haemophilus Infections; History, 20th Century; History, 21st Century; Humans; Japan; Macrolides; Nasal Polyps; Rhinitis; Sinusitis | 2016 |
Macrolide therapy of chronic rhinosinusitis.
Topics: Anti-Bacterial Agents; Biofilms; Chemotaxis, Leukocyte; Chronic Disease; Clarithromycin; Erythromycin; Humans; Macrolides; Rhinitis; Roxithromycin; Sinusitis | 2007 |
14 trial(s) available for clarithromycin and Nasal Catarrh
| Article | Year |
|---|---|
Introducing a Novel Combination Therapy with Macrolides for the Treatment of Chronic Rhinosinusitis: A Randomized Controlled Trial.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chronic Disease; Clarithromycin; Humans; Macrolides; Rhinitis; Single-Blind Method; Sinusitis; Treatment Outcome | 2022 |
A 10-Year Follow-Up of a Randomized Prospective Study of 2 Treatments for Chronic Rhinosinusitis Without Nasal Polyps and Investigation of the Impact of Gastroeosophageal Reflux Disease in the Resistance to Treatment.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Male; Middle Aged; Patient Acuity; Rhinitis; Sino-Nasal Outcome Test; Sinusitis; Steroids | 2021 |
Add-on effect of clarithromycin to oral steroids as post- operative therapy for chronic rhinosinusitis with nasal polyps: a randomised controlled trial.
Topics: Chronic Disease; Clarithromycin; Endoscopy; Humans; Nasal Polyps; Rhinitis; Steroids; Treatment Outcome | 2020 |
Lack of additional effects of long-term, low-dose clarithromycin combined treatment compared with topical steroids alone for chronic rhinosinusitis in China: a randomized, controlled trial.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Budesonide; China; Chronic Disease; Clarithromycin; Cytokines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nasal Polyps; Nasal Sprays; Rhinitis; Single-Blind Method; Sinusitis; Treatment Outcome; Young Adult | 2018 |
Comparison of efficacy of fluticasone propionate versus clarithromycin for postoperative treatment of different phenotypic chronic rhinosinusitis: a randomized controlled trial.
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Fluticasone; Humans; Nasal Polyps; Prospective Studies; Rhinitis; Single-Blind Method; Sinusitis | 2019 |
Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial.
Topics: Administration, Oral; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Comparative Effectiveness Research; Drug Administration Schedule; Endoscopy; Female; Humans; Male; Multicenter Studies as Topic; Nasal Polyps; Nasal Surgical Procedures; Pilot Projects; Randomized Controlled Trials as Topic; Rhinitis; Sinusitis; Time Factors; Treatment Outcome; United Kingdom | 2019 |
High and low doses of clarithromycin treatment are associated with different clinical efficacies and immunomodulatory properties in chronic rhinosinusitis.
Topics: Adult; Anti-Bacterial Agents; Biomarkers; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Female; Humans; Interleukin-5; Interleukin-8; Male; Middle Aged; Quality of Life; Rhinitis; Sinusitis; Surveys and Questionnaires; Treatment Outcome | 2014 |
Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery.
Topics: Adrenal Cortex Hormones; Adult; Chemotherapy, Adjuvant; Chronic Disease; Clarithromycin; Endoscopy; Eosinophil Cationic Protein; Female; Follow-Up Studies; Humans; Male; Mometasone Furoate; Nasal Polyps; Paranasal Sinuses; Pregnadienediols; Recurrence; Rhinitis; Rhinomanometry; Sinusitis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbocysteine; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nasal Polyps; Prospective Studies; Quality of Life; Rhinitis; Sinusitis; Tomography, X-Ray Computed | 2012 |
[Clinical observation of Clarithromycin combined with nasal steroid treatment for chronic rhinosinusitis].
Topics: Adolescent; Adult; Aged; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nasal Polyps; Rhinitis; Sinusitis; Treatment Outcome; Triamcinolone Acetonide; Young Adult | 2011 |
Prevalence of biofilms and their response to medical treatment in chronic rhinosinusitis without polyps.
Topics: Administration, Oral; Administration, Topical; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biofilms; Biopsy; Chronic Disease; Clarithromycin; Female; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Mometasone Furoate; Pregnadienediols; Prevalence; Rhinitis; Sinusitis; Statistics, Nonparametric | 2012 |
[The treatment of chronic polypous rhinosinusitis in the postoperative period with low doses of clarithromycin].
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nasal Mucosa; Nasal Polyps; Nasal Surgical Procedures; Paranasal Sinuses; Postoperative Complications; Radiography; Rhinitis; Secondary Prevention; Sinusitis; Time; Treatment Outcome | 2012 |
Optimal duration of macrolide treatment for chronic sinusitis after endoscopic sinus surgery.
Topics: Adult; Aged; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Combined Modality Therapy; Endoscopy; Humans; Middle Aged; Otorhinolaryngologic Surgical Procedures; Paranasal Sinuses; Rhinitis; Sinusitis; Time Factors; Treatment Outcome; Young Adult | 2013 |
Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Biological Transport; Clarithromycin; Elasticity; Humans; Methacholine Chloride; Mucus; Nasal Mucosa; Reference Values; Rhinitis; Suppuration; Viscosity | 1997 |
13 other study(ies) available for clarithromycin and Nasal Catarrh
| Article | Year |
|---|---|
Overexpression of hypoxia-inducible factor 1α is associated with neutrophilic inflammation in chronic rhinosinusitis with nasal polyps.
Topics: Adult; Anti-Bacterial Agents; Blotting, Western; Case-Control Studies; Chronic Disease; Clarithromycin; Cytokines; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Male; Middle Aged; Nasal Polyps; Neutrophils; Reverse Transcriptase Polymerase Chain Reaction; Rhinitis; RNA, Messenger; Sinusitis | 2020 |
Pharmacotherapy of Chronic Rhinosinusitis with a Focus on Clarithromycin: An Expert Opinion.
Topics: Chronic Disease; Clarithromycin; Expert Testimony; Humans; Quality of Life; Rhinitis | 2018 |
[The expression of VEGF and the regulation of clarithromycin on it in chronic rhinosinusitis with nasal polys].
Topics: Adult; Chronic Disease; Clarithromycin; Female; Humans; Male; Nasal Mucosa; Nasal Polyps; Rhinitis; Sinusitis; Vascular Endothelial Growth Factor A; Young Adult | 2014 |
Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model study.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Cell Survival; Chronic Disease; Clarithromycin; Cytokines; Dendritic Cells; Dexamethasone; Dose-Response Relationship, Drug; Epithelial Cells; Female; Gene Expression Regulation; Humans; Inflammation Mediators; Male; Middle Aged; Mifepristone; Models, Biological; Phenotype; Pilot Projects; Receptors, Pattern Recognition; Rhinitis; Sinusitis; T-Lymphocytes, Helper-Inducer | 2015 |
The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chronic Disease; Clarithromycin; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Medication Adherence; Middle Aged; Mometasone Furoate; Patient Selection; Prospective Studies; Rhinitis; Sinusitis; Therapeutic Irrigation; United Kingdom; Young Adult | 2017 |
Effects of long-term clarithromycin treatment on lavage-fluid markers of inflammation in chronic rhinosinusitis.
Topics: Adult; Anti-Bacterial Agents; Australia; Biomarkers; Bronchoalveolar Lavage Fluid; Chronic Disease; Clarithromycin; Cytokines; Female; Histamine; Histamine Agonists; Humans; Inflammation; Male; Middle Aged; Rhinitis; Sinusitis; Time | 2009 |
Evaluation of long-term clarithromycin treatment in adult Chinese Patients with chronic rhinosinusitis without nasal polyps.
Topics: Adult; Anti-Bacterial Agents; China; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Nasal Polyps; Prevalence; Rhinitis; Sinusitis; Time Factors; Treatment Outcome | 2011 |
[Long-term clarithromycin therapy in patients with chronic polypous rhinosinusitis].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Humans; Quality of Life; Rhinitis; Sinusitis | 2011 |
[Experience with treatment of chronic polypoid rhinosinusitis using low doses of clarithromycin in the postoperative period].
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Maxillary Sinusitis; Middle Aged; Nasal Polyps; Postoperative Period; Rhinitis; Secondary Prevention; Treatment Outcome | 2012 |
Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chronic Disease; Clarithromycin; Culture Techniques; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-5; Interleukin-8; Male; Middle Aged; Nasal Mucosa; Prednisolone; Rhinitis; Sinusitis | 2002 |
[Efficacy of clarithromycin (Fromilid) in treatment of uncomplicated acute bacterial rhinosinusitis in children].
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Female; Humans; Male; Retrospective Studies; Rhinitis; Sinusitis; Treatment Outcome | 2003 |
Is it spontaneous resolution or macrolide efficacy?
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Clarithromycin; Female; Gram-Negative Bacterial Infections; Humans; Infant; Macrolides; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Nasopharynx; Otitis Media with Effusion; Pneumococcal Infections; Rhinitis; Sinusitis; Streptococcus pneumoniae | 2004 |
Drug eruptions in children with ENT infections.
Topics: Acetaminophen; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Child; Child, Preschool; Clarithromycin; Clindamycin; Diagnosis, Differential; Drug Eruptions; Erythromycin; Female; Humans; Infant; Infections; Male; Otitis; Otorhinolaryngologic Diseases; Pharyngitis; Prospective Studies; Rhinitis; Risk Factors; Sinusitis; Stomatognathic Diseases; Tonsillitis | 2006 |